Published in Z Rheumatol on May 29, 1992
[Eosinophilia-myalgia syndrome. The clinical spectrum expands]. Z Rheumatol (1992) 0.75
Beta-defensins: linking innate and adaptive immunity through dendritic and T cell CCR6. Science (1999) 7.86
A peptide antibiotic from human skin. Nature (1997) 7.64
NOD2 (CARD15) mutations in Crohn's disease are associated with diminished mucosal alpha-defensin expression. Gut (2004) 4.39
Analysis of the induction of general stress proteins of Bacillus subtilis. Microbiology (1994) 4.16
Cytokine RANTES released by thrombin-stimulated platelets is a potent attractant for human eosinophils. J Exp Med (1992) 3.20
Mucoid Pseudomonas aeruginosa, TNF-alpha, and IL-1beta, but not IL-6, induce human beta-defensin-2 in respiratory epithelia. Am J Respir Cell Mol Biol (2000) 2.66
Elafin: an elastase-specific inhibitor of human skin. Purification, characterization, and complete amino acid sequence. J Biol Chem (1990) 2.23
The role of Schwann cells in the formation of "onion bulbs" found in chronic neuropathies. J Neuropathol Exp Neurol (1967) 2.13
Structure determination of a human lymphocyte derived neutrophil activating peptide (LYNAP). Biochem Biophys Res Commun (1988) 2.10
Identification of C5ades arg and an anionic neutrophil-activating peptide (ANAP) in psoriatic scales. J Invest Dermatol (1986) 1.96
Combined spa-exercise therapy is effective in patients with ankylosing spondylitis: a randomized controlled trial. Arthritis Rheum (2001) 1.86
Specific and general stress proteins in Bacillus subtilis--a two-deimensional protein electrophoresis study. Microbiology (1997) 1.86
A comprehensive two-dimensional map of cytosolic proteins of Bacillus subtilis. Electrophoresis (2001) 1.79
Localization of neutrophil-activating peptide-1/interleukin-8-immunoreactivity in normal and psoriatic skin. J Invest Dermatol (1991) 1.79
Altered ratio between axon diameter and myelin sheath thickness in regenerated nerve fibers. Brain Res (1972) 1.70
Changes of the ratio between myelin thickness and axon diameter in the human developing sural nerve. Acta Neuropathol (1978) 1.45
Increased plasma endothelin-1 levels in fibromyalgia syndrome. Rheumatology (Oxford) (2003) 1.44
The major dermatomyositis-specific Mi-2 autoantigen is a presumed helicase involved in transcriptional activation. Arthritis Rheum (1995) 1.44
Nonnative proteins induce expression of the Bacillus subtilis CIRCE regulon. J Bacteriol (1998) 1.41
[Pathogen-induced arthritis and autoantibody associated systemic diseases--diagnostic concepts in transition]. Z Rheumatol (1995) 1.39
[Fibromyalgia and Sjögren syndrome--clinical and methodological aspects]. Z Rheumatol (1996) 1.38
Bioactive interleukin-8 is expressed in wounds and enhances wound healing. J Surg Res (2000) 1.37
The registry of the German Network for Systemic Scleroderma: frequency of disease subsets and patterns of organ involvement. Rheumatology (Oxford) (2008) 1.32
What is the 'true' function of skin? Exp Dermatol (2002) 1.26
[Burden of illness. First routine report on socio-medical consequences of inflammatory rheumatic disease in Germany]. Z Rheumatol (2008) 1.26
Neutrophil attractant protein-1-immunoglobulin G immune complexes and free anti-NAP-1 antibody in normal human serum. J Clin Invest (1992) 1.25
The chemokine RANTES is secreted by human melanoma cells and is associated with enhanced tumour formation in nude mice. Br J Cancer (1999) 1.22
Th1- and Th2-type cytokines regulate the expression and production of eotaxin and RANTES by human lung fibroblasts. Am J Respir Cell Mol Biol (1999) 1.22
Amino-terminally modified RANTES analogues demonstrate differential effects on RANTES receptors. J Biol Chem (1999) 1.22
IL-4 induces eotaxin: a possible mechanism of selective eosinophil recruitment in helminth infection and atopy. J Immunol (1998) 1.20
Calcium potentials and tetrodotoxin-resistant sodium potentials in unmyelinated C fibres of biopsied human sural nerve. Neuroscience (1995) 1.19
[Ultrastructure of experimental allergic neuritis in the rabbit]. Acta Neuropathol (1970) 1.15
Identification of vegetative proteins for a two-dimensional protein index of Bacillus subtilis. Microbiology (1997) 1.14
Immunogenetic associations of scleroderma-related antinuclear antibodies. Arthritis Rheum (1990) 1.14
[The pathogenesis of INH-neuropathy. I. Fine structural similarities and differences to wallerian degeneration]. Acta Neuropathol (1970) 1.12
[Edema and necrosis in the gray and white substance in experimental brain injury. Light and electron microscopic investigations]. Acta Neuropathol (1965) 1.12
The ultrastructural morphology of the muscle fiber in myotonic dystrophy. Acta Neuropathol (1968) 1.11
[The fine structure of the neuromatous neurotization of nerve transplants]. Virchows Arch B Cell Pathol (1970) 1.11
Role of nasal interleukin-8 in neutrophil recruitment and activation in children with virus-induced asthma. Am J Respir Crit Care Med (1997) 1.10
Polymorphonuclear leukocyte chemotaxis in psoriasis: enhancement by self-activated serum. Br J Dermatol (1980) 1.10
Novel missense mutations in the glycogen-branching enzyme gene in adult polyglucosan body disease. Ann Neurol (2000) 1.09
[Guideline for the joint swelling symptom--primary physician problem management and referral indications. German Society of Rheumatology "Quality Assurance" Committee]. Z Rheumatol (2000) 1.09
Acute inflammatory effects of a monocyte-derived neutrophil-activating peptide in rabbit skin. Immunology (1989) 1.08
[Capillaroscopy. Procedure and nomenclature]. Z Rheumatol (2010) 1.06
Purification, structural analysis, and function of natural ATAC, a cytokine secreted by CD8(+) T cells. J Biol Chem (1997) 1.06
Recombinant human tumor necrosis factor alpha lacks chemotactic activity for human peripheral blood neutrophils and monocytes. Biochem Biophys Res Commun (1988) 1.06
[Trends in rehabilitation of patients with rheumatic diseases in Germany]. Z Rheumatol (2014) 1.06
Mapping of the gene encoding human beta-defensin-2 (DEFB2) to chromosome region 8p22-p23.1. Genomics (1997) 1.05
Expression profile of human defensins and antimicrobial proteins in oral tissues. J Oral Pathol Med (2001) 1.04
Laser speckle imaging with an active noise reduction scheme. Opt Express (2005) 1.04
Inflammatory properties of neutrophil-activating protein-1/interleukin 8 (NAP-1/IL-8) in human skin: a light- and electronmicroscopic study. J Invest Dermatol (1991) 1.03
Clinical and serological aspects of patients with anti-Jo-1 antibodies--an evolving spectrum of disease manifestations. Clin Rheumatol (2000) 1.02
Comparison of patients with and without digital ulcers in systemic sclerosis: detection of possible risk factors. Br J Dermatol (2009) 1.01
Immunocytochemical localization of the chemokines RANTES and MIP-1 alpha within human platelets and their release during storage. Int Arch Allergy Immunol (1995) 1.01
Eosinophil recruitment following allergen challenge is associated with the release of the chemokine RANTES into asthmatic airways. J Immunol (1996) 1.01
Genomic organization, sequence, and transcriptional regulation of the human eotaxin gene. Biochem Biophys Res Commun (1997) 1.01
Anoxia induced functional inactivation of neonatal respiratory neurones in vitro. Neuroreport (1994) 1.01
Skin sclerosis is only of limited value to identify SSc patients with severe manifestations--an analysis of a distinct patient subgroup of the German Systemic Sclerosis Network (DNSS) Register. Rheumatology (Oxford) (2009) 1.01
Induction, regulation, and function of soluble TRAP (CD40 ligand) during interaction of primary CD4+ CD45RA+ T cells with dendritic cells. Eur J Immunol (1996) 1.00
Early myocardial disease and cramping myalgia in Becker-type muscular dystrophy: a kindred. Neurology (1979) 1.00
[Ultrastructure of unmyelinated(Remak) nerve fibers in isoniazid neuropathy]. Acta Neuropathol (1970) 0.99
HLA-DR4 and Gm(1,3;5,21) are associated with U1-nRNP antibody positive connective tissue disease. Ann Rheum Dis (1987) 0.98
Proliferation of epineurial capillaries and smooth muscle cells in angiopathic peripheral neuropathy. Acta Neuropathol (1986) 0.98
Autosomal dominant distal myopathy: further evidence of a chromosome 14 locus. Neuromuscul Disord (2001) 0.98
Hepatocytes derived from adult stem cells. Transplant Proc (2008) 0.98
Detection of natural peptide antibiotics in human nasolacrimal ducts. Invest Ophthalmol Vis Sci (2001) 0.97
Production and characterization of monoclonal antibodies against the novel neutrophil activating peptide NAP/IL-8. J Immunol (1989) 0.97
5-Oxo-eicosanoids are potent eosinophil chemotactic factors. Functional characterization and structural requirements. J Biol Chem (1995) 0.97
Adult polyglucosan body disease: a postmortem correlation study. Neurology (2003) 0.97
The fine structure of de- and reinnervated muscle spindles. I. The increase, atrophy and "hypertrophy" of intrafusal muscle fibers. Acta Neuropathol (1974) 0.97
S-1 radiculopathy as a possible predisposing factor in focal myositis with unilateral hypertrophy of the calf muscles. J Neurol Sci (1999) 0.96
IgA-associated inhibition of polymorphonuclear leukocyte chemotaxis in neutrophilic dermatoses. J Invest Dermatol (1981) 0.96
Human monocyte chemotactic proteins-2 and 3 (MCP-2 and MCP-3) attract human eosinophils and desensitize the chemotactic responses towards RANTES. Biochem Biophys Res Commun (1994) 0.96
[Academy for Graduate and Continuing Education in Rheumatology]. Z Rheumatol (2004) 0.96
Is psoriasis a T-cell disease? Exp Dermatol (2000) 0.95
[Memorandum on the position and development of rehabilitation for patients with rheumatic diseases]. Z Rheumatol (1997) 0.95
Altered polymorphonuclear leukocyte responses in psoriasis: chemotaxis and degranulation. Br J Dermatol (1983) 0.94
Strong association of dermatomyositis-specific Mi-2 autoantibodies with a tryptophan at position 9 of the HLA-DR beta chain. Arthritis Rheum (1996) 0.94
The fine structure of denervated and reinnervated muscle spindles: morphometric study of intrafusal muscle fibers. Acta Neuropathol (1979) 0.94
Neutrophil-activating peptide 1/interleukin 8 mRNA expression and protein secretion by human monocytes: effect of cyclosporin A. Cytokine (1991) 0.94
Charcot-Marie-Tooth neuropathy type 2 and P0 point mutations: two novel amino acid substitutions (Asp61Gly; Tyr119Cys) and a possible "hotspot" on Thr124Met. Brain Pathol (2000) 0.94
[Unmyelinated nerve fibers in senile nerves and in late thalidomide neuropathy: a quantitative electron microscopic study (author's transl)]. Acta Neuropathol (1977) 0.93
Role of melanoma growth stimulatory activity (MGSA/gro) on keratinocyte function in wound healing. Arch Dermatol Res (1997) 0.93
Differential sensitivities of purified human eosinophils and neutrophils to defined chemotaxins. Scand J Immunol (1989) 0.93
Intracellular localization and release of eotaxin from normal eosinophils. FEBS Lett (1998) 0.93
Adult polyglucosan body myopathy with subclinical peripheral neuropathy: case report and review of diseases associated with polyglucosan body accumulation. Clin Neuropathol (1989) 0.92
Occurrence and characterization of peripheral nerve involvement in neurofibromatosis type 2. Brain (2002) 0.91
X-linked dominant Charcot-Marie-Tooth neuropathy: clinical, electrophysiological, and morphological phenotype in four families with different connexin32 mutations(1). J Neurol Sci (1999) 0.91
Nerve conduction changes and fine structural alterations of extra- and intrafusal muscle and nerve fibers in streptozotocin diabetic rats. Muscle Nerve (1995) 0.91
[Further education: a core responsibility of the German Society for Rheumatology and the Rheuma Academy]. Z Rheumatol (2011) 0.91
A new type of distal myopathy in two brothers. J Neurol (1981) 0.90
Transient absence of C5a-specific neutrophil function in inflammatory disorders of the skin. J Invest Dermatol (1985) 0.90
Identification of two endogenous neutrophil-activating peptides in psoriatic skin and inflammatory cells: C5ades arg and NAP. Dermatologica (1989) 0.90
[Relations between polyamines and nucleic acids. II. Biochemical and fine structural studies of peripheral nerves during Wallerian degeneration]. Brain Res (1970) 0.90
Ethylene oxide polyneuropathy: clinical follow-up study with morphometric and electron microscopic findings in a sural nerve biopsy. J Neurol (1985) 0.90
[Routine report on the medical rehabilitation of patients with musculoskeletal diseases]. Z Rheumatol (2005) 0.89
Identification of neutrophil chemotactic factors in bronchoalveolar lavage fluid of asthmatic patients. Clin Exp Allergy (1997) 0.89